Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Radical -xh acid – or anhydride – acid halide or salt thereof...
Patent
1995-06-29
1997-08-26
Dees, Jose G.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Radical -xh acid, or anhydride, acid halide or salt thereof...
514810, 514811, 514812, 514813, A61K 3119
Patent
active
056611846
ABSTRACT:
The present invention provides a method of treating substance dependence disorders using an agonist which acts at negatively coupled cAMP-linked metabotropic glutamate receptors.
REFERENCES:
Koch, "Microinjections . . . (trans-ACPD) . . . Amydala . . . Rats", Brain Research, vol. 629, 176-179 1993.
Y. Nakagawa et al., "(2S,3S,4S).alpha.-(Carboxycyclopropyl)-glycine is a novel agonist of metabotropic glutamate receptors," European J. Pharmacology, 184, 205-206 (1990).
Y. Hayashi et al., "Agonist analysis of 2-(carboxycyclopropyl)glycine isomers for cloned metabotropic glutamate receptor subtypes expressed in Chinese hamster ovary cells," Br. J. Pharmacol., 107, 539-543 (1992).
H. Shinozaki and M. Ishida, "Recent Advances in the Study of Glutamate Receptor Agonists," Asia Pacific J. of Pharmacol., 6, 293-316 (1991).
Canadian Journal of Pharmacology, XIIth International Congress of Pharmacology Abstracts, vol. 72, Supplement 1, issued 24 Jul. 1994, M.E. Fundytus, et al., "Acute ICV Injection of the Metabotropic Glutamate Receptor Agonists trans-ACPD Attenuates Morphine Withdrawal in Rats", p. 349, col. 2, Abstract No. P13.5.18.
Neuroscience Letters, vol. 162, issued 1993, abstract, Tizzanno et al, "Intracerebral 1S,3R-1-Aminocyclopentane-1,3-Dicarboxylic Acid (1S,3R-ACPD) Produces Limbic Seizures that are not Blocked by Ionotropic Glutamate Receptor Antagonists", pp. 12-16.
F. Nicoletti et al., "(1.sub.S, 1'.sub.R, 2'.sub.R, 3'.sub.R)-2-(2,3-Dicarboxycyclopropyl)glycine enhances quisqualate-stimulated inositol phospholipid hydrolysis in hippocampal slices," Eur. J. Pharmacol.-Molecular Pharmacol. Section, 245, 297-298 (1993).
M. Ishida et al., "A potent metabotropic glutamate receptor agonist: electrophysiological actions of a conformationally restricted glutamate analogue in the rat spinal cord and Xenopus oocytes," Brain Res., 537, 311-314 (1990).
M. Ishida et al., "A novel metabotropic glutamate receptor agonist: marked depression of monosynaptic excitation in the newborn rat isolated spinal cord," Br. J. Pharmacol., vol. 109, 1169-1177 (Aug. 1993), abstract.
V. Bruno et al., "Protective effect of the metabotropic glutamate receptor agonist, DCG-IV, against excitotoxic neuronal death," Eur. J. Pharmacol., 256, 109-112 (1994).
H, Kaba et al., "Induction of an Olfactory Memory by the Activation of a Metabotropic Glutamate Receptor," Science, 265, 262-264 (Jul. 8, 1994).
D.E. Jane et al., "Actions of two new antagonists showing selectively for different sub-types of metabotropic glutamate receptor in the neonatal rat spinal cord," Br. J. Pharmacol., 112, 809-816 (1994).
F. Nicoletti et al., "Effect of Metabotropic Glutamate Receptor Agonists in Excitotoxic or Apoptotic Neuronal Degeneration," Neuropschychopharmacology, 10 (3S), 623S (1994) May.
M. Mortensen et al., "The Effect of Lorazepam Tolerance and Withdrawal on Metabotropic Glutamate Receptor Function" Journal of Pharmacology and Experimental Therapeutics 274(1), (Mar. 27, 1995) pp. 155-163.
Alcohol Clin. Exp. Res., vol. 17 (4), S. A. Queen et al., "Dose and Age-Dependent Effects of Prenatal Ethanol Exposure . . . Metabotropic Glutamate Receptor . . . Hydrolysis", 1993, abstract.
Alcohol, vol. 11 (4), T. L. Smith, "Selective Effects of Ethanol Exposure on Metabotropic GlutamateProduces Limbic Seizures . . . Glutamate Receptor and Nucleotide . . . Astrocytes", 1994, abstract.
Molecular and Chemical Neuropathology, vol. 23 (1), P. G. Rhodes et al., "Prenatal Ethanol and Exposure Reduces Phosphoinositide Hydrolysis . . . Cell Cultures":, 1994, abstract.
Helton David R.
Kallman Mary Jeanne
Monn James A.
Schoepp Darryle D.
Tizzano Joseph P.
Boone David E.
Dees Jos,e G.
Eli Lilly and Company
Hay Martin A.
Leeds James P.
LandOfFree
Psychiatric agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Psychiatric agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Psychiatric agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1988941